Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06471569 · ClinicalTrials.gov registry record · NA

Role of Aging and Individual Variation in Exercise Training Responsiveness

A NA study of Obesity and Cardiovascular Diseases, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
26
Enrollment target
1
Study location

NCT06471569: Recruiting NA study of Obesity and Cardiovascular Diseases, sponsored by Duke University.

NCT06471569 is a NA study of Obesity and Cardiovascular Diseases that is actively recruiting participants, run by Duke University. The registered enrollment target is 26 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06471569, a NA study of Obesity and Cardiovascular Diseases, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
26 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to assess the effects of aging on markers of physical reserve and exercise-induced adaptations in resilience in older adults who completed a structured exercise program within the last 15 years (Parent trial: STRRIDE-PD; NCT00962962). This feasibility pilot study will enroll up to 26 participants to complete a 6-month aerobic exercise intervention.

Primary Outcome

Insulin sensitivity will be measured with a 2-hour oral glucose tolerance test

Interventions

  • BEHAVIORAL Low/Mod
  • BEHAVIORAL High/Mod
  • BEHAVIORAL High/Vig

Study Locations (1)

North Carolina

  • Duke Center for Living - Durham

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2025-04-02
Est. Completion 2027-03-31
Phase NA
Duke University

1,725 total trials

What NCT06471569 shows while recruiting

NCT06471569 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (97% lower).

The record links to 4 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Low/Mod is the first listed.

NCT06471569 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06471569 about?

NCT06471569 is a clinical study titled "Role of Aging and Individual Variation in Exercise Training Responsiveness". The primary purpose of this study is to assess the effects of aging on markers of physical reserve and exercise-induced adaptations in resilience in older adults who completed a structured exercise program within the last 15 years (Parent trial: STRRIDE-PD; NCT00962962). This feasibility pilot study...

What is the current status of trial NCT06471569?

This trial is currently recruiting. It is a NA study. The enrollment target is 26 participants. The study started on 2025-04-02. Estimated completion is 2027-03-31.

What conditions does trial NCT06471569 study?

This clinical trial studies the following conditions: Obesity, Cardiovascular Diseases, Insulin Resistance, Prediabetic State.

What interventions are being tested in trial NCT06471569?

The interventions under investigation include: Low/Mod (BEHAVIORAL), High/Mod (BEHAVIORAL), High/Vig (BEHAVIORAL).

Who is sponsoring clinical trial NCT06471569?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06471569 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06471569's enrollment target sits among peer trials

26 897th of 1053 higher than 151 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

  • NCT04913064 · 26 participants · NA

    Effects of White Button Mushroom on Inflammation in Obese Postmenopausal Women at High Risk of Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06471569, the US trial registry maintained by the National Library of Medicine. NCT06471569 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.